Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print June 23, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.030114
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
71/4/1374    most recent
biolreprod.104.030114v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizuno, M.
Right arrow Articles by Morgan, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizuno, M.
Right arrow Articles by Morgan, B. P.
Agricola
Right arrow Articles by Mizuno, M.
Right arrow Articles by Morgan, B. P.
BIOLOGY OF REPRODUCTION 71, 1374–1383 (2004)
DOI: 10.1095/biolreprod.104.030114
© 2004 by the Society for the Study of Reproduction, Inc.


Immunology

Rat Membrane Cofactor Protein (MCP; CD46) Is Expressed Only in the Acrosome of Developing and Mature Spermatozoa and Mediates Binding to Immobilized Activated C31

Masashi Mizuno3, Claire L. Harris3, Peter M. Johnson4, and B. Paul Morgan2,3

Complement Biology Group,3 Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Cardiff CF14 4XN, United Kingdom Department of Immunology,4 University of Liverpool, Liverpool L69 3BX, United Kingdom


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The rat analogue of the complement regulator membrane cofactor protein (MCP; CD46) was recently cloned and analysis at the mRNA level suggested that expression was restricted to testis. In light of the proposed roles of human MCP in sperm-egg interaction, we undertook to analyze rat MCP expression at the protein level in order better to address its putative role in fertilization. Recombinant fusion proteins comprising antibody Fc and specific domains of rat MCP were generated and used to develop a monoclonal antibody, MM.1, specific for rat MCP. Immunohistochemistry using these reagents confirmed the reported testis-specific expression of MCP in sexually mature rats and demonstrated that MCP was expressed only by spermatozoa and their immediate precursors in spermiogenesis, spermatids. Prepubertal male rats did not express MCP, and there was no evidence of MCP expression at any site in the embryo. Spermatozoal MCP expression was restricted to the inner acrosomal membrane, exposed only after fixation or induction of the acrosome reaction. Acrosome-reacted but not unreacted spermatozoa bound methylamine-activated C3 immobilized on plastic. The retention of MCP at this subcellular site, which is probably crucial to sperm-egg interaction, and the functional demonstration of binding to activated C3 strengthen suggestions from human studies that MCP may play an important role in fertilization. The reagents and results described here will enable studies of the role of spermatozoal MCP in sperm-egg interaction using a relevant animal model system.

acrosome reaction, immunology, sperm, spermatogenesis, testis


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Membrane cofactor protein (MCP; CD46) is a membrane-associated complement regulator that protects self by acting as a cofactor for the factor I (fI)-mediated cleavage of C3b and C4b, hence inactivating complement enzymes deposited on host cells [13]. Human MCP exists in multiple isomeric forms and is broadly distributed, expressed on most cell types with the notable exception of erythrocytes [4, 5]. Perhaps as a consequence of this near-ubiquitous expression, MCP has been utilized as a receptor by several pathogens, including the measles virus, human herpes virus-6, groups B and D adenoviruses, group A Streptococcus, and piliated Neisseria [612].

A role for MCP in reproduction was first suggested by the demonstration that the human spermatozoal protein (trophoblast-leukocyte common antigen; TLX) was identical to MCP [1315]. TLX/MCP was detectable on sperm only after the acrosome reaction, indicating that it was restricted to the inner acrosomal membrane and effectively excluding a role in complement regulation on spermatozoa, as it would be only transiently expressed in vivo. MCP on human spermatozoa differs from MCP in other tissues in that it has a smaller molecular mass (43–50 kDa versus 51–58 kDa and 59–68 kDa for the major ubiquitous MCP isoforms) due to trimming of N-linked carbohydrate to less complex structures [16, 17]. Spermatozoal MCP may contain exclusively cytoplasmic tail 2, and the three N-linked sugar groups are trimmed to small, simple structures [18]. Surprisingly, incubation with monoclonal antibodies (mAbs) against the first short consensus repeat (SCR) domain of MCP inhibited the interaction of human sperm with oocytes in both heterologous (hamster egg) and homologous (human egg) systems [1921]. These observations provoked several investigators to propose specific roles for MCP in sperm-egg interaction, although no common model has yet emerged. The association of abnormalities of expression of MCP in testis with infertility in a small percentage of infertile men supports a role for MCP in sperm function but leaves many questions unanswered [22, 23].

MCP expression has also been characterized in nonhuman primates, pigs, and rodents. In primates and pigs, MCP is widely distributed, being expressed on most cell types including erythrocytes [24, 25]. In contrast, MCP in mice, rats, and guinea pigs is predominantly or exclusively expressed in the testis when assessed by Northern blot analyses of mRNA expression [2628]. In mice and rats, the role of MCP as a ubiquitous cell surface complement regulator is subsumed by the rodent-specific regulator Crry [29]. Despite the presence of Crry, expression of MCP has been retained in male reproductive tissues, adding support to the conjecture that MCP may play an important noncomplement role at this site. Lacking is any detailed analysis of rodent MCP expression at the protein level, and, without this information, it is impossible to predict whether rodents are appropriate models for examining the functional role of spermatozoal MCP.

In order to address this deficit, we have generated a specific mAb against rat MCP using a recombinant fusion protein comprising the second and third SCR domains fused to human IgG-Fc. We have used these reagents to characterize the expression of the protein in immature and adult rats as well as during embryonic development and have assessed the cofactor function of the expressed protein.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Tissue Culture

All tissue culture reagents were purchased from Gibco-BRL (Paisley, UK). The Chinese hamster ovary (CHO) cell line, SP2/0-A14 cells (the myeloma fusion partner), and Jurkat human T cell line were obtained from the European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). The CHO cell line was grown in Ham F12 medium with 5% fetal calf serum (FCS), 50 U/ml penicillin/streptomycin, 1 µg/ml amphotericin B, 2 mM glutamine, and 1 mM sodium pyruvate. SP2/0-A14 cells and Jurkat cells were grown in RPMI 1640 medium supplemented with 10% FCS and the same additives.

Proteins

Human and rat C3 and fI were prepared in-house according to published methods [30]. Soluble complement receptor 1 (sCR1) was a gift from T Cell Sciences Inc. (Needham, MA). Human and rat C3 were methylamine-activated (hC3ma and rC3ma, respectively) by incubating C3 (0.5 mg/ml in borate-buffered saline, pH 8.0) with 0.1 M methylamine for 2 h at 37°C. The protein was dialyzed into PBS. The C3/30 mAb against human C3b has been described previously [31].

Preparation of Recombinant Ig Fusion Proteins

Ig fusion proteins comprising either rat MCP SCR 2 and 3 (MCP23-Ig) or rat CD59 (CD59-Ig) attached to IgG-Fc were prepared as described [32, 33]. Briefly, cDNA encoding SCR2 and 3 of rat MCP or the extracellular domain of rat CD59 [28, 34] was cloned into the expression vector pDR2{Delta}EF1{alpha} (gift from Dr I. Anegon, INSERM U437, Nantes, France) upstream of and in-frame with DNA encoding the hinge and Fc domains of human IgG. For rat MCP, the signal sequence of CD33 was included as described previously [32]. Vent DNA proofreading polymerase was used in the polymerase chain reaction (PCR) reactions, and sequencing the products confirmed that no errors had been introduced by PCR. CHO cells were transfected with these plasmids using lipofectamine (Gibco BRL) according to the manufacturer's instructions. Stable lines were selected with 400 µg/ml hygromycin B (Gibco BRL) in Ham F12 medium with 10% FCS and maintained in hygromycin B (100µ/ml) in Ham F12 medium with 5% FCS.

To isolate the fusion protein, spent medium was collected and passed over a Prosep A column (Bioprocessing Ltd, Consett, UK); the column was washed with PBS and with 0.1 M citrate buffer, pH 5.0, to remove contaminating bovine Ig; and then the fusion protein was eluted with 0.1 M glycine/HCl, pH 2.5. The eluted protein was neutralized, dialyzed into PBS, and concentrated by ultrafiltration.

Expression of Rat MCP in CHO Cells

CHO cells were transfected with the full-length rat MCP cDNA [28] in the expression vector pDR2{Delta}EF1{alpha}, as described previously (CHO/ MCP). Control cells were transfected with the vector alone (vector control; CHO/VC). Transfectants were selected and maintained in Ham F12 medium with hygromycin as described previously.

Cell lysates of CHO/MCP, CHO/VC, spermatozoa, or Jurkat cells were prepared by solubilization in 1% NP40 in PBS for 30 min on ice. Lysates were centrifuged at 5000 x g for 15 min at 4°C and the supernatants stored at –80°C.

MAb Production and Purification

BALB/c mice were immunized with MCP23-Ig; mAb were generated using published methods [32]. Fusion wells were screened in ELISA for reactivity against MCP23-Ig and the control CD59-Ig proteins, and those wells specifically positive for the former were cloned by limiting dilution. Monoclonal populations were rescreened, isotyped using the IsoStrip mouse monoclonal antibody isotype kit (Boehringer Mannheim, Indianapolis, IN), and expanded in culture.

The mAb were purified from culture supernatant on Prosep A as described earlier [32]. For purification of IgG1 mAb, the hybridoma culture supernatant was mixed 1:1 (v:v) with 1.5 M glycine and 3 M NaCl and then adjusted to pH 8.9 with NaOH prior to application to the column. The column was then washed with the same buffer at pH 8.9 and bound IgG1 eluted with 0.1 M citrate phosphate buffer, pH 5.18. The eluted protein was dialyzed into PBS and concentrated by ultrafiltration.

The mAb were fluorescein isothiocyanate (FITC)-labeled by incubation with NHS-FITC according to the manufacturer's instructions (Pierce, Rockford, IL).

Spermatozoa Preparation and Analysis

Motile epididymal spermatozoa were obtained by a modification of the swim-up technique for human spermatozoa as described previously [35]. Briefly, epididymis from an adult male Wistar rat humanely killed using UK Home Office approved methods was minced in 3 ml of Ham F12 medium and incubated at room temperature for 15 min to allow sedimentation of large cellular aggregates. The supernatant was removed to a fresh tube and carefully overlaid with 3 ml of Ham F12 medium at room temperature. The tube was incubated for 90 min at 37°C, and the top 2.5 ml of Ham F12 medium, which contained motile spermatozoa, were then carefully removed. Swim-up isolated spermatozoa were used for immunofluorescence (IF) analyses, for preparing sperm lysates, and for the acrosome reaction.

For IF, 20 µl of the sample were spotted onto glass slides and air-dried overnight. The slides were fixed in acetone at room temperature for 5 min and stored at –20°C until use. To prepare sperm lysates, swim-up spermatozoa from the cauda epididymis of a single rat were pelleted by centrifugation and incubated with mixing in 1 µl of lysate buffer (PBS containing 2% NP40, 1 mM phenylmethylsulfonyl fluoride, 10 mM EDTA, 1 µg/ml leupeptin, and 1 µg/ml pepstatin) for 30 min on ice. Insoluble debris was removed by centrifugation (5000 x g, 15 min at 4°C) and the supernatant lysate stored in aliquots at –80°C.

The acrosome reaction was performed using minor modifications of a published method [35]. Briefly, the swim-up spermatozoa (1 x 106 in 1 ml of Ham F12 medium) were incubated for 1 h at 37°C with the calcium ionophore A23187 (Sigma-Aldrich, Dorset, UK) at 1 µM to induce the acrosome reaction. Control cells were incubated without ionophore. Acrosome-reacted and control spermatozoa were gently smeared on glass slides and immediately air-dried. Viability of spermatozoa following acrosome reaction was >80% as assessed by exclusion of propidium iodide. To confirm the subcellular localization of rat MCP, we used an acrosome-specific mAb, 18-6 (kind gift of Dr. H. Moore; University of Sheffield, UK) [36]. This mAb was generated by immunization of mice with hamster spermatozoa and is recognized as a marker of the acrosome in hamster and human [36]. The antigen recognized by 18-6 is undefined. Here we first confirmed that mAb 18-6 specifically stained the acrosome in rat spermatozoa. For double staining, mAb 18-6 (neat tissue culture supernatant, 50 µl) was first incubated on the glass slides smeared with the spermatozoa, followed by rhodamine-labeled donkey anti-mouse IgG (1: 200 in PBS; Jackson ImmunoResearch Laboratories, Philadelphia, PA). After this procedure, specimens were blocked with nonimmune mouse IgG and finally incubated with 50 µl of FITC-MM.1 anti-MCP mAb (diluted 1:50 in PBS).

Fresh human semen was obtained by masturbation after 3 days of abstinence from healthy volunteer donors of proven fertility. Informed consent was obtained from all donors in accordance with local ethical guidelines. After liquefaction at room temperature, samples were either fractionated by centrifugation at 1000 x g to separate spermatozoa from seminal plasma or used unfractionated. Whole semen was mixed 1:1 with lysis buffer and incubated as described previously prior to separation on SDS-PAGE. Separated spermatozoa were washed in PBS prior to suspension in lysis buffer and analyses. Human spermatozoa were also isolated by swim-up as described previously.

Preparation of Tissue Lysates

Epididymis and testis were obtained fresh from killed rats. The tissue was finely minced, suspended in 3 ml lysate buffer (for a pair of epididymi or one testis), and incubated for 60 min on ice. After incubation, insoluble debris was removed by centrifugation (15 000 x g, 15 min at 4°C), and supernatants were stored in aliquots at –80°C until use.

SDS-PAGE and Western Blot Analysis

Lysates were mixed 1:1 with sample buffer for SDS-PAGE and separated under nonreducing conditions on 10% gels. Separated proteins were transferred to nitrocellulose membranes (Schleicher & Schuell, London, UK), and the membrane was blocked with 5% (w:v) nonfat milk in PBS (PBS-M). Membranes were then probed with the primary mAb diluted in PBS-M, washed in PBS containing 0.1% Tween-20 (PBS-T), then probed with horseradish peroxidase (HRPO)-conjugated goat anti-mouse Ig (BioRad) in PBS-M. To detect Ig-fusion proteins in Western blots, the membrane was incubated with HRPO-conjugated goat anti-human Fc antibody (1:1000 in PBS-M; Sigma Aldrich). To detect polyclonal antibody in Western blots, the membrane was incubated with HRPO-conjugated donkey anti-rabbit IgG antibody (1:1000 in PBS-M; Jackson). After further washing in PBS-T, bands were developed using ECL (Perbio Science; Helsingborg, Sweden) and captured on autoradiographic film (Kodak).

Immunohistochemical Analysis of Rat MCP Distribution

Male and female Wistar rats (12–16 wk) were killed, and the major organs and tissues, including heart, lung, liver, spleen, kidney, intestine, adrenal gland, bladder, ovary, oviduct, uterus, skin, eye, adipose tissue, skeletal muscle, femoral artery, femoral vein, cerebrum, cerebellum, spinal cord, sciatic nerve, testis, and epidermis, were removed, cut into blocks, and snap-frozen in isopentane at –40°C. Organs and tissues were also collected from 2-wk-old male Wistar rats, and intact rat embryos (15-day gestation) were additionally obtained for analysis. Frozen tissues were sectioned in a cryostat at 7 µm for brain, epididymis, and adipose tissue; 15 µm for ovary; and 5 µm for all other tissues. All sections were fixed in acetone at room temperature for 5 min. To observe the binding of mAbs, fixed sections were incubated with the optimal dilution (5 µg/ml) of mAb (determined by prior titration experiments), followed by FITC-labeled goat anti-mouse IgG antibody (1:200; BioRad) preabsorbed with normal Wistar rat serum. Counterstaining of nuclei was obtained by addition of DAPI (4'-6-diamino-2-phenylindole-2 HCl; 100 ng/ml final concentration; Sigma) with the secondary antibody.

Purification of Native Rat MCP

An affinity matrix was made comprising 5 mg of the mAb immobilized on CNBr-activated Sepharose 4B according to the manufacturer's instructions (Amersham Biosciences; Uppsala, Sweden). Tissue or cell lysates were diluted 1:1 in PBS containing 1 M NaCl and 0.2% NP40 and applied to the matrix packed in a column. After washing in the same buffer, bound MCP was eluted with 0.1 M glycine (pH 2.5) in 0.2% NP40, dialyzed into PBS/0.2% NP40, and concentrated by ultrafiltration. The purified protein was characterized by SDS-PAGE and Western blot analysis.

Cofactor Assay

All procedures were performed essentially as previously described [37]. For assessment of cofactor activity, hC3ma (50 µg/ml final concentration) was incubated in a final volume of 50 µl with rat fI (10 µg/ml) and either fractions containing rat MCP from the affinity column or sCR1 as a positive control. Samples were incubated for 4 h at 37°C, and the reaction was stopped by adding an equal volume of reducing SDS-PAGE loading buffer. The samples were briefly boiled, then loaded onto a 10% SDS-PAGE. Gels were Western blotted and blots probed with polyclonal sheep anti-human C3d (1:1000 in PBS-M; The Binding Site, Birmingham, UK) followed by HRPO-labeled donkey anti-sheep IgG (1:1000 in PBS-M; Sigma) as the secondary antibody and developed as described previously.

Deglycosylation of Rat Testis MCP

O-glycosidase and N-glycosidase (Roche, Mannheim, Germany) were used for the removal of O-linked and N-linked sugars, respectively, from rat MCP according to the manufacturer's instructions. Briefly, rat testis lysate prepared as described previously or a similar lysate prepared from the unfractionated cell pellet from human semen as a positive control was diluted (2:9 v:v) in 0.1 M sodium phosphate buffer, pH 7.4, containing 20 mM EDTA, 0.1% sodium dodecyl sulfate, and 1% NP40. N-glycosidase (0.5 U) and/or O-glycosidase (0.25 mU) was added to 60-µl aliquots of diluted lysate and incubated at 37°C for 24 h. Neuraminidase (Roche; 25 mU) was included in O-deglycosylation tubes to remove terminal disaccharide. Samples were then separated on SDS-PAGE and Western blotted as described previously. Blots were probed using the specific mAb or a polyclonal rabbit anti-human MCP (kind gift of Dr. T. Seya, Osaka, Japan).

Binding of C3ma by Rat Spermatozoa and Competition with MCP Fusion Protein

Rat spermatozoa, freshly isolated by swim-up and either acrosome-reacted or unreacted, were incubated at 106/ml in Ham F12 medium with hC3ma (50 µg/ml) at 37°C for 30 min and washed in PBS. The cells were then smeared onto glass slides, air-dried, fixed by brief immersion in acetone, and again air-dried. The fixed cells were washed in cold PBS, then stained by incubation with the anti-human C3b mAb C3/30 (10 µg/ml in PBS containing 1% BSA, 30 min on ice) followed by FITC-labeled donkey anti-mouse IgG (1:200 in PBS containing 1% BSA, 30 min on ice; Jackson) prior to mounting and imaging. The hC3ma was used in these preliminary experiments because of the availability of a mAb to detect its binding.

To confirm binding in a homologous system, rC3ma (50 µg/ml in 0.15 M bicarbonate buffer, pH 9.6) was used to coat alternate rows of wells in a 12-well plastic plate (Nunclon delta surface; NUNC, Roskilde, Denmark) by incubation at 37°C for 2 h. All wells were then blocked by incubation with 2% BSA in PBS followed by washing in PBS. Swim-up acrosome-reacted or unreacted spermatozoa (viability >80%), suspended at 106/ml in Ham F12 medium were applied to pairs of rC3ma-coated and control (block only) wells in triplicate and incubated for 1 h at 37°C. Wells were gently washed five times with cold Ham F12 medium. Bound spermatozoa were counted under 200x magnification in each well. The binding ratio of acrosome-reacted or unreacted spermatozoa to C3ma-coated and control wells was calculated for each pair of wells following the formula:



In some experiments, the fusion protein MCP23-Ig at either 0.5, 0.1, or 0.01 mg/ml in PBS was preincubated for 15 min at 37°C with the C3ma-coated and BSA-coated wells prior to the addition of acrosome-reacted or unreacted spermatozoa as described previously. Control wells were pre incubated with PBS alone. The binding ratios were calculated as done previously.

Data are shown as the mean ± SEM of the ratios for triplicate sets of wells. The statistical analysis was performed by Student paired t-test, and a P-value less than 0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Generation of a Specific mAb Against Rat MCP23-Ig Fusion Protein

Although numerous hybridoma supernatants were posi tive for antibody reactive with MCP23-Ig in early screen ing, only a single strongly positive clone was retained through subsequent limiting dilution cloning. This IgG1 mAb, termed MM.1, was strongly reactive against MCP23-Ig but not CD59-Ig in ELISA and Western blotting (data not shown). The MM.1 mAb specifically detected rat MCP as a single band of approximate molecular mass (Mr) 38 kDa in Western blots of lysates from transfected CHO cells but not vector control cells (Fig. 1A).



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 1. Western blotting with the MM.1 mAb (A) and glycosylation of testis-derived rat MCP (B). A) Tissue and cell lysates were separated on SDS-PAGE and probed with MM.1 mAb or appropriate isotype-matched control mAb. CHO/MCP, lysate of rat MCP-expressing CHO cells probed with MM.1 mAb; CHO/VC, lysate of vector control CHO cells probed with MM.1 mAb; testis lysate, lysate of rat testis probed with MM.1 mAb; secondary con, lysate of rat testis probed with isotype-control control mAb. A polyclonal anti-human MCP detects bands at ~45 kDa and ~60 kDa in a lysate derived from unfractionated human semen (Hu semen), at ~45 kDa in lysate of human sperm (Hu sperm lys), and at 60 kDa in lysate of Jurkat cells (Jurkat lys). B) Rat testis-derived MCP, either untreated (untreated/rat), treated with O-glycosidase and neuraminidase (O-gly/rat), treated with N-glycosidase (N-gly/rat), or treated with N-glycosidase, O-glycosidase, and neuraminidase (N+O-gly/rat) and separated on SDS-PAGE. A reduction in molecular mass is seen only in the presence of N-glycosidase. The blot was probed with MM.1 mAb. As the positive control of deglycosylation, human MCP derived from cell-free seminal plasma, either untreated (Untreated/hu), treated with N-glycosidase (N-gly/hu), treated with O-glycosidase and neuraminidase (O-gly/hu), or treated with N-glycosidase, O-glycosidase, and neuraminidase (N+O-gly/hu). The blot was probed with polyclonal anti-human MCP

The Anti-Rat MCP mAb MM.1 Detects Native Rat MCP in Cell and Tissue Lysates

In Western blots of lysates from swim-up spermatozoa, epididymis, and testis, the MM.1 mAb specifically detected a single band of ~38 kDa (Fig. 1A shows results from a testis lysate; identical results were obtained with spermatozoa and epididymis). Lysate from unfractionated human semen, purified human spermatozoa, and the Jurkat human T cell line were also run and stained with rabbit polyclonal anti-human MCP as a comparator (Fig. 1A). This revealed the expected spermatozoa-specific MCP band in unfractionated seminal plasma and purified spermatozoa at an approximate size of 45 kDa, compatible with the published size [16]. A MCP band at approximately 60 kDa was present in Jurkat cells and also in unfractionated seminal plasma, presumably contributed by MCP from leukocytes in this preparation. Rat spermatozoal MCP was consistently smaller than human sperm MCP by ~5 kDa.

Enzymatic Deglycosylation Reveals the Presence of N-Linked Sugars in Rat MCP

Treatment of immunoaffinity purified rat MCP with N-glycosidase reduced the molecular mass by approximately 3–5 kDa, demonstrating the presence of N-linked sugar on the protein (Fig. 1B). Treatment with O-glycosidase did not detectably alter the molecular mass, suggesting that O-linked sugars were resistant to enzymatic removal (Fig. 1B). As controls for the activities of the deglycosidases, human MCP from sperm-free seminal plasma (high-molecular mass form) was treated in an identical manner. Treatment with either N-glycosidase or O-glycosidase reduced the molecular mass of human MCP by 8–10 kDa, and the combination of the two enzymes reduced the molecular mass of human MCP by approximately 18 kDa (Fig. 1B). The doublets observed in human MCP likely represent the commonly expressed BC and C isoforms.

MCP Is Expressed Only in the Male Reproductive Tract in Adult Rats

Testis and spermatozoa in the lumen of the epididymis stained strongly with the MM.1 mAb (Table 1). An exhaustive search failed to reveal any specific staining with the MM.1 mAb in any other cells or tissues. Of particular relevance, no staining was observed in the female reproductive tissues, ovary, oviduct, and uterus; oocytes were clearly visible in the ovary and were negative.


View this table:
[in this window]
[in a new window]
 
TABLE 1. MCP distribution in the rat testis and epididymis before and after puberty

In the testis, differential staining with the MM.1 mAb was noted on cells in various stages of spermiogenesis (Fig. 2, A–F). The earliest precursors, spermatogonia, in the outer regions of the seminiferous tubules and round spermatocytes were not stained. Elongated spermatids, the immediate precursors of spermatozoa, stained strongly in the vicinity of the developing acrosome. Sertoli cells and phagocytic and secretory cells situated close to the lumen of the seminiferous tubule were not stained. Interstitial areas between the seminiferous tubules including the hormone-secreting Leydig cells and vascular elements, were also negative. Immature spermatozoa in the lumen of the seminal vesicles were strongly stained but only in the acrosomal region (Fig. 2, A–D).



View larger version (95K):
[in this window]
[in a new window]
 
FIG. 2. The distribution of rat MCP in adult rat testis and epididymis. AF) adult rat testis. G and H) Adult rat epididymis. IL) Acetone-fixed swim-up spermatozoa. A, C, E, G, and I) Staining with the MM.1 mAb; (B, D, F, H, and J) Double staining with the mAb (green) and DAPI (blue) to show nuclei. K and L) Isotype-matched controls for the MM.1 mAb (with DAPI staining). Arrowheads show early spermatids (A), intermediate spermatids (C), and late spermatids (E). Arrows indicate the acrosome region of immature spermatozoa in the testis (A and C) and mature spermatozoa in the epididymis (G). Asterisks show the lumen of the seminiferous tubules. Original magnification: AF x400; G and H x200; IL taken at x400 and further magnified x2 postcapture

In the epididymis, staining was noted only on the spermatozoa in the lumen of the epididymal duct and was again restricted to the acrosomal region of spermatozoa (Fig. 2, G and H); epididymal epithelium and interstitium were not stained.

In immature male rats (2 wk), which lack late spermatozoal precursors and mature sperm and have seminiferous tubules containing predominantly Sertoli cells, the testis and epididymis were completely negative for MM.1 mAb staining (Table 1). Sections from embryos (15-day gestation) were also stained with the MM.1 mAb and were negative.

Rat MCP Is Expressed Only on the Inner Acrosomal Membrane

Whereas more than 95% of unfixed freshly isolated spermatozoa were not stained with the MM.1 mAb, following acetone fixation, 100% of sperm cells were stained with MM.1, and staining was restricted to the acrosomal region (Fig. 2, I and J). There was no positive staining with an isotype-matched control IgG (Fig. 2, K and L). To confirm the apparent restriction of expression to the inner acrosomal membrane, the acrosome reaction was induced by incubation of fresh sperm with the calcium ionophore A23187. After ionophore treatment, more than 50% of unfixed sperm were strongly stained by MM.1 with a typical acrosome-restricted pattern, confirming that MCP on rat spermatozoa was sequestered on the inner acrosomal membranes (Fig. 3, A and E). MM.1 staining on acrosome reacted spermatozoa completely coincided with that of mAb 18-6 (Fig. 3E), a specific marker of the acrosome (Fig. 3C) [35]. In contrast, unfixed swim-up sperm were not stained with either MM.1 or mAb 18-6 (Fig. 3, B, D, and F).



View larger version (72K):
[in this window]
[in a new window]
 
FIG. 3. Staining for rat MCP, acrosome-specific marker, and C3ma binding after the acrosome reaction. A, C, and E) Unfixed spermatozoa that have been induced to acrosome react by ionophore treatment. B, D, and F) Unfixed unreacted spermatozoa. A and B) Stained with MM.1 (green). C and D) Stained with mAb 18-6 to specifically stain the acrosome (red). E and F) Double staining with MM.1 and 18-6 (yellow). The staining was negative by isotype-matched control for the MM.1 and 18-6 mAb as Figures 2, K and L (data not shown). GJ) Acrosome-reacted (G and H) or unreacted (I and J) spermatozoa were incubated with hC3ma and fixed prior to staining with anti-C3b mAb. E, F, H, and J have been counterstained with DAPI (blue). Arrows (A, C, and E) indicate the acrosome region of rat spermatozoa. Arrows (G and H) indicate the positive staining of anti-C3b mAb. Original magnification is x400. In GJ, images are further magnified x2 postcapture

Acrosome-Reacted Rat Spermatozoa Bind Methylamine-Activated C3

When unfixed, acrosome-reacted rat spermatozoa were incubated with hC3ma and then stained with the C3/30 mAb to detect bound hC3ma, 20%–30% of the cells were stained (Fig. 3, G and H). The staining was not solely acrosomal (evident from comparison with plates 3A and 3C) but was restricted to the head region of spermatozoa and was patchy/granular in appearance. Non-acrosome-reacted unfixed spermatozoa did not bind hC3ma (Fig. 3, I and J). In the absence of added hC3ma, the C3/30 mAb did not stain spermatozoa (data not shown).

In order to address further this C3-binding activity, unfixed acrosome-reacted spermatozoa were incubated in wells coated with rC3ma. Many cells became firmly adherent, through the head region, to the plastic (Fig. 4A). In contrast, very few nonreacted spermatozoa bound to rC3ma-coated wells (Fig. 4B), and neither acrosome-reacted nor nonreacted spermatozoa bound BSA-coated control wells (Fig. 4, C and D). Bound spermatozoa were counted in triplicate wells and results expressed as a ratio of binding to rC3ma-coated and control wells such that no increased binding would give a ratio of 0 (Fig. 4E). The mean binding ratio was 4.88 for acrosome-reacted spermatozoa versus 0.61 for nonreacted cells (P < 0.05). Binding to control wells was consistently low and was not different for acrosome-reacted and nonreacted cells.



View larger version (59K):
[in this window]
[in a new window]
 
FIG. 4. Interaction between acrosome-reacted spermatozoa and C3ma. A) Acrosome-reacted spermatozoa binding to rC3ma-coated plastic plate well. B) Fresh, unreacted spermatozoa binding to rC3ma-coated plastic plate well. C and D) BSA-coated wells as controls for A and B, respectively. Original magnification x200. E) Summary of the data for triplicate sets of wells for each experimental condition. The binding of acrosome-reacted spermatozoa to rC3ma was significantly greater than binding of unreacted spermatozoa. The latter binding was similar to that found on control BSA-coated wells. The formula for calculation of the binding ratio is given in the text. Data are shown as the mean ± SEM of triplicate sets. The experiment was replicated on three occasions, and the data shown are representative of these replicate experiments. F) Binding of acrosome-reacted spermatozoa to rC3ma was almost completely abrogated by preincubation of the coated wells with the MCP23-Ig fusion protein at 0.01 mg/ml. The results are means of four wells for each experimental condition (±SEM), and the experiment was replicated twice

The specificity of the binding reaction for MCP was addressed by examining competition by the MCP23-Ig fusion protein. Preincubation of the rC3ma-coated wells with MCP23-Ig completely blocked binding of acrosome-reacted spermatozoa at all concentrations tested; the data shown are with MCP23-Ig at the lowest concentration, 0.01 mg/ml (Fig. 4E). The CD59-Ig fusion protein used as a control caused minimal inhibition of binding of spermatozoa at this concentration (not shown).

Cofactor Function of Sperm-Derived Rat MCP

We have shown previously that a recombinant soluble form of rat MCP has cofactor activity for the fI-mediated cleavage of methylamine-activated human C3 [28]. Here, we have sought to extend these observations to the native protein.

Used as a positive control, sCR1 catalyzed the specific production of a 68-kDa {alpha}-chain cleavage product and also a subsequent fI cleavage event, unique to CR1, to produce a 41-kDa fragment (Fig. 5A, lane 1; Fig. 5B). Rat MCP, partially purified from testis lysate by immunoaffinity chromatography on MM.1, catalyzed the first of these cleavage events in the presence of fI, yielding the 68-kDa {alpha}-chain product with no further cleavage. Omission of fI prevented cleavage catalyzed by either sCR1 or rat MCP, confirming the specificity of the reaction (Fig. 5A, lanes 3 and 5). In the absence of any cofactor, fI did not cleave C3ma (Fig. 5A, lane 2).



View larger version (27K):
[in this window]
[in a new window]
 
FIG. 5. Cofactor assay of testis-derived rat MCP. A) Cofactor assay. Lane 1: hC3ma, fI, and sCR1; cleavage products at 68 kDa (first cleavage events) and 41 kDa (subsequent cleavage event) are detected in the blot using a polyclonal anti-human C3d antibody. Lanes 2 and 3: omission of either sCR1 or fI, respectively, prevents cleavage of hC3ma. Lane 4: hC3ma and rat MCP with fI; only the 68-kDa product of the first cleavage event is generated. Lane 5: hC3ma and rat MCP without fI; no cleavage of hC3ma is detected. B) Schematic representation of expected cleavage fragments from the previously mentioned experimental protocol


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
MCP is a multitasking molecule in humans. A key membrane regulator of complement, vital for prevention of damage to self at sites of complement activation, it is also an important signaling molecule with newly discovered roles in cell adhesion, costimulation, and modulation of T cell function and fate [3841]. Despite the clear importance of MCP in homeostasis, studies of mRNA expression in rodents have indicated that expression in peripheral tissues is minimal or absent, with the complement regulatory tasks of MCP being subsumed by the unique rodent regulator Crry [2628, 42]. MCP in humans has been subverted by numerous pathogens as a cell surface receptor [7], and it is attractive to speculate that selective pressure from these pathogens has caused the loss of global MCP expression in rodents. Indeed, this speculation is given substance by the recent demonstration that the widely expressed MCP in New World primates comprises only three SCR domains [43]. The missing domain, SCR1, is the site utilized by measles virus; loss of this domain in monkeys eliminates measles binding without compromising complement regulatory activity.

In rats, mice, and guinea pigs, MCP mRNA is significantly expressed only in testis [26, 28, 42], implying that the molecule has been retained at this site because it plays an essential and unique role in this organ. In New World primates, only MCP expressed in testis retains SCR1, again implying a special role [43]. In man and primates, MCP is strongly expressed on the inner acrosomal membrane of spermatozoa, a site that is exposed only to the external milieu immediately prior to interaction with the egg, and transgenic expression of human MCP in mice yields an identical acrosome-restricted expression [18].

In order to utilize rodents as models for the study of the role of MCP in sperm-egg interaction, it is first necessary to discover whether MCP is expressed at the relevant sites. Our analyses by Northern blotting of mRNA expression in rat tissues demonstrated that MCP was strongly expressed only in testis; however, Reverse transcription-polymerase chain reaction analyses did indicate low levels of mRNA in other tissues [28]. In order to further analyze the distribution of rat MCP and to confirm the cellular and subcellular localization of the protein in testis, we undertook to generate mAb against rat MCP. Here, we report a specific mAb reactive against rat MCP, MM.1, that has been obtained by immunizing mice with a Fc fusion protein containing the second and third SCR domains of the protein. The mAb detected a protein band of 38 kDa in Western blots of lysates from epididymis, testis, and sperm purified by swim-up. MCP on human sperm has a reported approximate size of 45 kDa [16], and we found a similar size in our analyses (Fig. 1). In humans, sperm express only the C2 isoform of MCP, containing the short STP-C and the 23 amino acid cytoplasmic tail 2; the low molecular mass of sperm MCP compared with that of the C2 isoform in other tissues is caused by the postsynthetic trimming of the three large N-linked carbohydrate groups to small, simple structures [18]. The predominant mRNA species obtained from rat testis comprised four SCR domains: a short STP region resembling STP C in humans, undefined and transmembrane regions, and a very short cytoplasmic region of just seven amino acids and related to the intracytoplasmic anchor of human MCP [28, 42]. Absence of the tail region in rat MCP likely explains the lower apparent molecular mass when compared with human sperm MCP. Rat MCP also differs from human in that the N-glycosylation site in SCR2 is absent; enzymatic N-deglycosylation of MCP in rat testis lysate caused a decrease in molecular mass of 3–5 kDa, suggesting that the two remaining N-glycans were simple structures as described for human sperm MCP in humans and in the human MCP transgenic mouse [18]. O-deglycosylation did not detectably alter the molecular mass, indicating that the O-linked sugars were resistant to digestion, as reported for MCP on human sperm [18]. Testis-derived rat MCP expressed cofactor activity for fI-mediated cleavage of C3b, confirming that it was the functional analogue of human MCP.

An immunohistological survey of rat tissues using the MM.1 mAb demonstrated that MCP is expressed only in the testis and epididymis from adult rats, more specifically, only by spermatozoa and late spermatozoal precursors. Early precursors in the process of spermiogenesis, spermatogonia, and spermatocytes were negative, as were the interdigitating Sertoli cells in the seminal vesicles. The staining pattern on fixed spermatozoa and precursors mirrored the course of acrosome formation [44]. MCP was not detected in female reproductive tissues, such as ovary, oviduct, and uterus, and was absent in the testis prior to puberty. Acrosome-restricted expression was confirmed in isolated spermatozoa where staining was detected only after fixation or induction of the acrosome reaction. This observation was further supported by demonstration of colocalization with mAb 18-6, an acrosome-specific mAb [36]. These results resemble the findings in humans, where sperm MCP expression is restricted to the inner acrosomal membrane; indeed, staining with anti-MCP is used as an indicator of the acrosome reaction in clinical analyses of sperm function [45, 46].

Expression of MCP correlated precisely with the appearance of the acrosome in late precursors and mature spermatozoa. The acrosome reaction, involving exocytic exposure of the inner acrosomal membrane and release of acrosomal contents, occurs after the sperm has made contact with the cells of the cumulus and zona pellucida complex that surrounds the oocyte and is essential to enable penetration of the zona [44, 47]. Enzymes released from the acrosome aid penetration, and receptors on the inner acrosomal membrane mediate oocyte binding and fusion events. The nature of the interacting molecules is incompletely understood, and the part that MCP plays in this complex process remains unknown. A decade ago, Anderson and colleagues [48] demonstrated that MCP on acrosome-reacted human spermatozoa specifically bound dimeric C3b and implicated this association in the adhesion of sperm and oocyte. These authors suggested that C3b or other C3 fragments bind MCP on sperm as well as complement receptors on the oocyte, providing a bridging interaction essential for fertilization. However, mAbs that block the C3b-binding site on MCP did not efficiently block sperm-oocyte interaction, whereas mAb binding SCR1 in MCP did block this interaction, indicating that sites other than the C3b-binding site are involved in the association with spermatozoa [1921]. Here, we have shown that acrosome-reacted rat spermatozoa also express an MCP-dependent capacity to bind immobilized activated C3 and that sperm MCP has fI cofactor activity. Studies are ongoing to address the roles of activated C3 and MCP in sperm-oocyte interactions in rats.

The observation that some infertile males may have an unexplained sperm-specific MCP deletion, while others have low levels of soluble MCP in seminal plasma, lends further weight to suggested involvement of MCP in fertilization [17, 23, 49]. However, C3 deficiency in humans and mouse is not associated with infertility, weakening the case for an essential role of C3 in the process. While this work was in preparation, others reported MCP-gene deleted mice whose phenotype was surprising [50]. Far from being infertile, the male mice were apparently hyperfertile and produced larger litter sizes than MCP-positive controls. Analyses of sperm in vitro demonstrated instability of the acrosome and an accelerated acrosome reaction, suggesting a role for MCP in the maintenance of acrosome integrity. No clear explanation for these confounding results has yet emerged.

The demonstration that MCP in the rat is expressed exclusively on the inner acrosomal membrane and the availability of a specific mAb against rat MCP, as well as recombinant protein, open new possibilities for experimentation. It will now be possible to examine the effects of both MCP blockade with mAb and addition of soluble rat MCP on in vitro sperm-oocyte interaction, on sperm survival in the face of complement attack, and on in vivo fertility. These studies will enable the roles and mechanisms of action of MCP in sperm survival and sperm-egg interaction to be elucidated, providing new avenues for investigation of these processes in humans.


    ACKNOWLEDGMENTS
 
We thank The Wellcome Trust for financial support through the award of program grant 068590. M.M. was supported as a Visiting Fellow by a Bursary from UWCM.


    FOOTNOTES
 
1 Supported by The Wellcome Trust (program support to B.P.M.) and a Departmental Bursary to M.M. Back

2 Correspondence: B. Paul Morgan, Complement Biology Group, Department of Medical Biochemistry and Immunology, University of Wales College of Medicine, Henry Wellcome Building, Heath Park, Cardiff CF14 4XN, United Kingdom. FAX: 44 2920744905; morganbp{at}cardiff.ac.uk Back

Received: 24 March 2004.

First decision: 13 April 2004.

Accepted: 8 June 2004.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Liszewski MK, Post TW, Atkinson JP. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu Rev Immunol 1991 9:431-455[CrossRef][Medline]
  2. Oglesby TJ, Allen CJ, Liszewski MK, White DJ, Atkinson JP. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 1992 175:1547-1551[Abstract/Free Full Text]
  3. Liszewski MK, Atkinson JP. Membrane cofactor protein. Curr Topics Microbiol Immunol 1992 178:45-60[Medline]
  4. Post TW, Liszewski MK, Adams EM, Tedja I, Miller EA, Atkinson JP. Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype. J Exp Med 1991 174:93-102[Abstract/Free Full Text]
  5. Liszewski MK, Tedja I, Atkinson JP. Membrane cofactor protein (CD46) of complement: processing differences related to alternatively spliced cytoplasmic domains. J Biol Chem 1994 269:10776-10779[Abstract/Free Full Text]
  6. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993 75:295-305[CrossRef][Medline]
  7. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993 67:6025-6032[Abstract/Free Full Text]
  8. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P. CD46 is a cellular receptor for human herpesvirus 6. Cell 1999 99:817-827[CrossRef][Medline]
  9. Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol 1997 25:639-647[CrossRef][Medline]
  10. Okada N, Liszewski MK, Atkinson JP, Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A 1995 92:2489-2493[Abstract/Free Full Text]
  11. Gaggar A, Shayakhmetov DM, Lieber A. CD46 is a cellular receptor for group B adenoviruses. Nat Med 2003 9:1408-1412[CrossRef][Medline]
  12. Wu E, Trauger SA, Pache L, Mullen TM, von Seggem DJ, Siuzdak G, Nemerow GR. Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol 2004 78:3897-3905[Abstract/Free Full Text]
  13. Anderson DJ, Michaelson JS, Johnson PM. Trophoblast/leukocyte-common antigen is expressed by human testicular germ cells and appears on the surface of acrosome-reacted sperm. Biol Reprod 1989 41:285-293[Abstract]
  14. Purcell DF, McKenzie IF, Lublin DM, Johnson PM, Atkinson JP, Oglesby TJ, Deacon NJ. The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology 1990 70:155-161[Medline]
  15. Fenichel P, Dohr G, Grivaux C, Cervoni F, Donzeau M, Hsi BL. Localization and characterization of the acrosomal antigen recognized by GB24 on human spermatozoa. Mol Reprod Dev 1990 27:173-178[CrossRef][Medline]
  16. Cervoni F, Oglesby TJ, Adams EM, Milesifluet C, Nickells M, Fenichel P, Atkinson JP, Hsi BL. Identification and characterization of membrane cofactor protein of human spermatozoa. J Immunol 1992 148:1431-1437[Abstract]
  17. Seya T, Hara T, Matsumoto M, Kiyohara H, Nakanishi I, Kinouchi T, Okabe M, Shimizu A, Akedo H. Membrane cofactor protein (MCP, CD46) in seminal plasma and on spermatozoa in normal and "sterile" subjects. Eur J Immunol 1993 23:1322-1327[Medline]
  18. Riley RC, Kemper C, Leung M, Atkinson JP. Characterization of human membrane cofactor protein (MCP; CD46) on spermatozoa. Mol Reprod Dev 2002 62:534-546[CrossRef][Medline]
  19. Okabe M, Ying X, Nagira M, Ikawa M, Kohama Y, Mimura T, Tanaka K. Homology of an acrosome-reacted sperm-specific antigen to CD46. J Pharmacobio-Dyn 1992 15:455-459[Medline]
  20. Taylor CT, Biljan MM, Kingsland CR, Johnson PM. Inhibition of human spermatozoon-oocyte interaction in vitro by monoclonal antibodies to CD46 (membrane cofactor protein). Hum Reprod 1994 9:907-911[Abstract/Free Full Text]
  21. D'Cruz OJ, Lambert H, Haas GG Jr. Expression of CD15 (Lewisx) antigen on human sperm and its role in sperm-egg interaction. Am J Reprod Immunol 1997 37:172-183
  22. Kitamura M, Matsumiya K, Yamanaka M, Takahara S, Hara T, Matsumoto M, Namiki M, Okuyama A, Seya T. Possible association of infertility with sperm-specific abnormality of CD46. J Reprod Immunol 1997 33:83-88[CrossRef][Medline]
  23. Nomura M, Kitamura M, Matsumiya K, Tsujimura A, Okuyama A, Matsumoto M, Toyoshima K, Seya T. Genomic analysis of idiopathic infertile patients with sperm-specific depletion of CD46. Exp Clin Immunogenet 2001 18:42-50[CrossRef][Medline]
  24. Hsu EC, Dorig RE, Sarangi F, Marcil A, Iorio C, Richardson CD. Artificial mutations and natural variations in the CD46 molecules from human and monkey cells define regions important for measles virus binding. J Virol 1997 71:6144-6154[Abstract]
  25. van den Berg CW, Perez de la Lastra JM, Llanes D, Morgan BP. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP). J Immunol 1997 158:1703-1709[Abstract]
  26. Hosokawa M, Nonaka M, Okada N, Nonaka M, Okada H. Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis. J Immunol 1996 157:4946-4952[Abstract]
  27. Tsujimura A, Shida K, Kitamura M, Nomura M, Takeda J, Tanaka H, Matsumoto M, Matsumiya K, Okuyama A, Nishimune Y, Okabe M, Seya T. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem J 1998 330:163-168
  28. Mead R, Hinchliffe SJ, Morgan BP. Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46). Immunology 1999 98:137-143[CrossRef][Medline]
  29. Quigg RJ, Lo CF, Alexander JJ, Sneed IA, Moxley G. Molecular characterization of rat Crry: widespread distribution of two alternative forms of Crry mRNA. Immunogenetics 1995 42:362-367[Medline]
  30. van den Berg CW. Purification of complement components, regulators and receptors by classical methods. Methods Mol Biol 2000 150:15-60[Medline]
  31. Kemp PA, Spragg JH, Brown JC, Morgan BP, Gunn CA, Taylor PW. Immunohistochemical determination of complement activation in joint tissues of patients with rheumatoid arthritis and osteoarthritis using neoantigen-specific monoclonal antibodies. J Clin Lab Immunol 1992 37:147-162[Medline]
  32. Harris CL, Lublin DM, Morgan BP. Efficient generation of monoclonal antibodies for specific protein domains using recombinant immunoglobulin fusion proteins: pitfalls and solutions. J Immunol Methods 2002 268:245-258[CrossRef][Medline]
  33. Harris CL, Williams AS, Linton SM, Morgan BP. Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. Clin Exp Immunol 2002 129:198-207[CrossRef][Medline]
  34. Rushmere NK, Harrison RA, van den Berg CW, Morgan BP. Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site. Biochem J 1994 304:595-601
  35. Harris CL, Vigar MA, Rey Nores JE, Horejsi V, Labeta MO, Morgan BP. The lipopolysaccharide co-receptor CD14 is present and functional in seminal plasma and expressed on spermatozoa. Immunology 2001 104:317-323[CrossRef][Medline]
  36. Moore HDM, Smith CA, Hartman TD, Bye AP. Visualization and characterization of the acrosome reaction of human spermatozoa by immunolocalization with monoclonal antibody. Gam Res 1987 17:245-259
  37. Harris CL. Functional assays for complement regulators. Methods Mol Biol 2000 150:83-102[Medline]
  38. Zaffran Y, Destaing O, Roux A, Ory S, Nheu T, Jurdic P, Rabourdin-Combe C, Astier AL. CD46/CD3 costimulation induces morphological changes of human T cells and activation of Vav, Rac, and extracellular signal-regulated kinase mitogen-activated protein kinase. J Immunol 2001 167:6780-6785[Abstract/Free Full Text]
  39. Marie JC, Astier AL, Rivailler P, Rabourdin-Combe C, Wild TF, Horvat B. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol 2002 3:659-666[Medline]
  40. Astier A, Trescol-Biemont MC, Azocar O, Lamouille B, Rabourdin-Combe C. Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation. J Immunol 2000 164:6091-6095[Abstract/Free Full Text]
  41. Kemper C, Chan AC, Green JM, Brett KA, Murphy KM, Atkinson JP. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003 421:388-392[CrossRef][Medline]
  42. Miwa T, Nonaka M, Okada N, Wakana S, Shiroishi T, Okada H. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 1998 48:363-371[CrossRef][Medline]
  43. Riley RC, Tannenbaum PL, Abbott DH, Atkinson JP. Cutting edge: inhibiting measles virus infection but promoting reproduction: an explanation for splicing and tissue-specific expression of CD46. J Immunol 2002 169:5405-5409[Abstract/Free Full Text]
  44. Abou-Haila A, Tulsiani DR. Mammalian sperm acrosome: formation, contents, and function. Arch Biochem Biophys 2000 379:173-182[CrossRef][Medline]
  45. Jaiswal BS, Eisenbach M, Tur-Kaspa I. 1999. Detection of partial and complete acrosome reaction in human spermatozoa: which inducers and probes to use?. Mol Hum Reprod 1999 5:214-219[Abstract/Free Full Text]
  46. Kawamoto A, Ohashi K, Kishikawa H, Zhu LQ, Azuma C, Murata Y. Two-color fluorescence staining of lectin and anti-CD46 antibody to assess acrosomal status. Fertil Steril 1999 71:497-501[CrossRef][Medline]
  47. Primakoff P, Myles DG. Penetration, adhesion, and fusion in mammalian sperm-egg interaction. Science 2002 296:2183-2185[Abstract/Free Full Text]
  48. Anderson DJ, Abbott AF, Jack RM. The role of complement component C3b and its receptors in sperm-oocyte interaction. Proc Natl Acad Sci U S A 1993 90:10051-10055[Abstract/Free Full Text]
  49. McLaughlin PJ, Holland SJ, Taylor CT, Olah KS, Lewis-Jones DI, Hara T, Seya T, Johnson PM. Soluble CD46 (membrane cofactor protein, MCP) in human reproductive tract fluids. J Reprod Immunol 1996 31:209-219[CrossRef][Medline]
  50. Inoue N, Ikawa M, Nakanishi T, Matsumoto M, Nomura M, Seya T, Okabe M. Disruption of mouse CD46 causes an accelerated spontaneous acrosome reaction in sperm. Mol Cell Biol 2003 23:2614-2622[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
ReproductionHome page
P. M Johnson, L. E Clift, P. Andrlikova, M. Jursova, B. F Flanagan, J. A Cummerson, P. Stopka, and K. Dvorakova-Hortova
Rapid sperm acrosome reaction in the absence of acrosomal CD46 expression in promiscuous field mice (Apodemus)
Reproduction, December 1, 2007; 134(6): 739 - 747.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Mizuno, M. Nozaki, N. Morine, N. Suzuki, K. Nishikawa, B. P. Morgan, and S. Matsuo
A Protein Toxin from the Sea Anemone Phyllodiscus semoni Targets the Kidney and Causes a Severe Renal Injury with Predominant Glomerular Endothelial Damage
Am. J. Pathol., August 1, 2007; 171(2): 402 - 414.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Mizuno, C. L. Harris, N. Suzuki, S. Matsuo, and B. P. Morgan
Expression of CD46 in Developing Rat Spermatozoa: Ultrastructural Localization and Utility as a Marker of the Various Stages of the Seminiferous Tubuli
Biol Reprod, April 1, 2005; 72(4): 908 - 915.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
71/4/1374    most recent
biolreprod.104.030114v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mizuno, M.
Right arrow Articles by Morgan, B. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizuno, M.
Right arrow